Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

15.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

6.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial.

Diabetes technology & therapeutics·2026
Same author

The protective effect of high-intensity interval exercise compared with continuous moderate exercise on glycaemic decline is more pronounced in the postabsorptive vs postprandial state in adults with type 1 diabetes: a randomised crossover trial.

Diabetologia·2026
Same author

Effects of a 50% versus 100% pre-prandial insulin bolus reduction to improve glycemic safety during postprandial continuous and intermittent exercise in adults with type 1 diabetes treated with multiple daily injections.

Frontiers in endocrinology·2026
Same author

Author Correction: A Bayesian decision support system for automated insulin doses in adults with type 1 diabetes on multiple daily injections: a randomized controlled trial.

Nature communications·2026
Same author

Topical application of cannabidiol for muscle recovery after exercise-induced muscle damage: a randomized, double-blinded pilot study.

Journal of cannabis research·2026
Same author

Residential Neighbourhood Environments and Health Behaviours Among Children and Adolescents Initiating Obesity Management Care: Secondary Analyses of Data From the CANadian Paediatric Weight Management Registry (CANPWR).

Pediatric obesity·2026

Related Experiment Video

Updated: Apr 13, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.9K

Post-exercise Glucose Management in Type 1 Diabetes: Comparing Carbohydrate Intake and Insulin Reduction Strategies.

Sémah Tagougui1, Elsa Heyman2, Nadine Taleb3

  • 1Université de Lille, Université d'Artois, Université du Littoral Côte d'Opale, ULR 7369 - URePSSS, Lille, France.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|April 12, 2026
PubMed
Summary

Managing blood glucose after exercise in type 1 diabetes (T1D) using continuous subcutaneous insulin infusion can be achieved through basal insulin reduction, which significantly delays hypoglycemia compared to snack-based strategies.

Keywords:
carbohydrate snacksinsulin reduction strategiesnocturnal hypoglycemiapost-exercise hypoglycemiatype 1 diabetes

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.4K

Related Experiment Videos

Last Updated: Apr 13, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.9K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

13.4K

Area of Science:

  • Endocrinology and Metabolism
  • Exercise Physiology
  • Diabetes Management

Background:

  • Post-exercise hypoglycemia is a significant concern for individuals with type 1 diabetes (T1D) using continuous subcutaneous insulin infusion (CSII).
  • Effective glucose management strategies are crucial to mitigate risks associated with exercise in T1D.
  • Understanding the impact of different CSII adjustments on glucose control post-exercise is vital.

Purpose of the Study:

  • To compare the efficacy of two distinct post-exercise glucose management strategies in T1D patients on CSII.
  • To evaluate blood glucose stability and time to first hypoglycemic event under different CSII adjustment protocols.

Main Methods:

  • 46 adults and adolescents with T1D performed a 60-minute ergocycling session.
  • Participants were randomized to either a 20% basal insulin reduction with reduced dinner bolus, or a post-exercise snack with a modified insulin bolus.
  • Continuous glucose monitoring was employed for 13 hours post-exercise to assess glucose profiles and hypoglycemia.

Main Results:

  • No significant differences were observed in overall blood glucose stability (time in range 4.0-10.0 mmol/L) between the two strategies.
  • Both strategies showed comparable time spent below 4.0 mmol/L, though high inter-individual variability was noted.
  • The basal insulin reduction strategy significantly delayed the onset of the first hypoglycemic event (140 min vs. 83 min, p=0.04).

Conclusions:

  • Both basal insulin reduction and snack-based strategies offer comparable blood glucose stability post-exercise in T1D patients on CSII.
  • Basal insulin reduction demonstrates a significant clinical advantage by delaying the onset of post-exercise hypoglycemia.
  • This suggests basal insulin adjustment is a potentially superior strategy for preventing early hypoglycemia after exercise.